Cryo-Cell International (NYSEARCA:CCEL) Shares Dip on Mixed Quarter Despite Earnings Beat

Cryo-Cell reported Q2 2026 earnings with a net income surprise of $0.07 per share, beating $0.00 estimates, though revenue slipped 2% YoY to $7.8M, causing after-hours shares to dip 4.8%.